Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.165
-0.065 (-5.28%)
Feb 4, 2026, 2:21 PM EST - Market open
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $53.42 million as of February 4, 2026. Its market cap has decreased by -38.01% in one year.
Market Cap
53.42M
Enterprise Value
48.04M
1-Year Change
-38.01%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $53.42M, a decrease of -25.56%. That is a compound annual growth rate of -3.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 56.40M | -36.60% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 69.23M |
| Kazia Therapeutics | 63.85M |
| BeyondSpring | 63.33M |
| NRx Pharmaceuticals | 62.17M |
| Tevogen Bio Holdings | 61.20M |
| InflaRx | 59.76M |
| Nutriband | 58.23M |
| TScan Therapeutics | 57.88M |